Cue biopharma reports qtrly loss per share of $0.37

Cue biopharma reports fourth quarter and full year 2019 financial results and recent business highlights.qtrly collaboration revenue of about $1.0 million versus $0.3 million.qtrly loss per share $0.37.q4 earnings per share view $-0.45, revenue view $873000.00 -- refinitiv ibes data.

CUE Ratings Summary

CUE Quant Ranking